Daurismo

Daurismo (glasdegib) is an oral medication used to treat certain types of cancer. This prescription drug is designed to target specific cells in the body, offering a potential therapeutic option for eligible patients.

Daurismo is primarily used in the treatment of acute myeloid leukemia (AML), a type of blood cancer. It works by interfering with the growth and spread of cancer cells. Patients typically use Daurismo as part of a broader treatment plan, which may include other medications or therapies. The specific uses of Daurismo should be determined by a healthcare provider based on individual patient needs.

Common effects of Daurismo may include fatigue, nausea, and muscle pain. Some patients may also experience changes in taste, diarrhea, or swelling in the arms and legs. These effects can vary from person to person, and not everyone will experience them. It's important to discuss any concerns about side effects with a healthcare provider.

Daurismo should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should inform their healthcare provider about any other medications they are taking to avoid potential interactions. Pregnant women or those planning to become pregnant should consult their healthcare provider before using Daurismo.

Daurismo may interact with certain medications, including those that are metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs, vitamins, and herbal supplements. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy or safety of Daurismo.